| Company/Division name | FUJIFILM Diosynth Biotechnologies U.S.A. |
| Parent company | FUJIFILM Holdings Corporation |
| Type of work | Manufacturing |
| If manufacturing, is the company a contract manufacturer? | Yes |
| Reshoring category: | Foreign Direct Investment |
| Year reshoring announced: | 2020 |
| Capital investment ($): | 54 |
| Country(ies) from which reshored: | Japan |
| City reshored to: | Morrisville |
| State(s) reshored to: | NC |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | biomanufacturing, gene therapies |
| What domestic positive factors made reshoring more attractive? | Lead time/Time to market, Under-utilized capacity, Other, import replacement |
